The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. by Sperber, Henrik et al.
UC Davis
UC Davis Previously Published Works
Title
The metabolome regulates the epigenetic landscape during naive-to-primed human 
embryonic stem cell transition.
Permalink
https://escholarship.org/uc/item/30n0d04m
Journal
Nature cell biology, 17(12)
ISSN
1465-7392
Authors
Sperber, Henrik
Mathieu, Julie
Wang, Yuliang
et al.
Publication Date
2015-12-01
DOI
10.1038/ncb3264
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
The metabolome regulates the epigenetic landscape during 
naïve to primed human embryonic stem cell transition
Henrik Sperber1,2,3,*, Julie Mathieu1,2,*, Yuliang Wang4,5,*, Amy Ferreccio1,2, Jennifer 
Hesson2, Zhuojin Xu2, Karin A. Fischer1,2, Arikketh Devi1,2,6, Damien Detraux1,2, Haiwei 
Gu2,7, Stephanie L. Battle2,8, Megan Showalter9, Cristina Valensisi2,8, Jason H. Bielas10,11, 
Nolan G. Ericson10, Lilyana Margaretha2, Aaron M. Robitaille2, Daciana Margineantu10, 
Oliver Fiehn9, David Hockenbery10, C. Anthony Blau1,2, Daniel Raftery2,7,10, Adam 
Margolin4,5, R. David Hawkins2,8, Randall T. Moon2, Carol B. Ware2, and Hannele Ruohola-
Baker1,2
1Department of Biochemistry, Seattle, WA
2Institute for Stem Cell and Regenerative Medicine, Seattle, WA
3Department of Chemistry, University of Washington, Seattle, WA
4Sage Bionetworks, Seattle, WA
5Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR
6Department of Genetic Engineering, SRM University, Kattankulathur, India
7Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, 
University of Washington, CA
8Department of Medicine, Division of Medical Genetics and Department of Genome Sciences, 
University of Washington, CA
9University of California Davis Genome Center, CA
10Fred Hutchinson Cancer Research Center, Seattle, WA, USA
11Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA
Abstract
For nearly a century developmental biologists have recognized that cells from embryos can differ 
in their potential to differentiate into distinct cell types. Recently, it has been recognized that 
embryonic stem cells derived from both mice and humans display two stable yet epigenetically 
distinct states of pluripotency, naïve and primed. We now show that nicotinamide-N-methyl 
transferase (NNMT) and metabolic state regulate pluripotency in hESCs. Specifically, in naïve 
hESCs NNMT and its enzymatic product 1-methylnicotinamide (1-MNA) are highly upregulated, 
and NNMT is required for low SAM levels and H3K27me3 repressive state. NNMT consumes 
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SAM in naïve cells, making it unavailable for histone methylation that represses Wnt and activates 
HIF pathway in primed hESCs. These data support the hypothesis that the metabolome regulates 
the epigenetic landscape of the earliest steps in human development.
INTRODUCTION
Pluripotent stem cells are able to self-renew and have the capacity to regenerate all tissues in 
the body. These cells hold promise for understanding early human development as well as 
developing therapies in regenerative medicine. Recent findings have revealed that 
pluripotency does not represent a single defined state; diverse states of pluripotency, with 
differences in measurable characteristics relating to gene expression, epigenetics and cellular 
phenotype, provide an experimental system for studying potential key regulators that 
constrain or expand the developmental capacity of pluripotent cells1–4. Two stable 
pluripotent states have been derived in the mouse, and now in humans; preimplantation 
naïve and postimplantation primed ESC states5–12 . Since naïve, preimplantation human 
embryonic stem cells (hESCs) show higher developmental potential than postimplantation, 
primed hESCs8,12, it is critical to understand the key molecular differences between these 
pluripotent cell types.
Metabolic signatures are highly characteristic for a cell and may act as a leading cause for 
cell fate changes13–20. Recent data have shown that pluripotent stem cells have a unique 
metabolic pattern. The naïve to primed mouse ESC transition accompanies a dramatic 
metabolic switch from bivalent to highly glycolytic state20. However, primed state of inert 
mitochondria rapidly changes to highly respiring mitochondria during further differentiation. 
It is not yet understood how and why the pluripotent cells enter the highly glycolytic, 
metabolically cancer-like (Warburg effect) state and how a differentiating cell leaves this 
state.
In mouse embryonic stem cells (mESCs) threonine and S-adenosyl methionine (SAM) 
metabolism are coupled resulting in regulation of histone methylation marks21. Methionine 
and SAM are also required for the self renewal of hESCs, since depletion of SAM leads to 
reduced H3K4me3 marks and defects in maintenance of the hESC state22. SAM therefore is 
shown to be a key regulator for maintaining ESC undifferentiated state and regulating their 
differentiation. However, little is known about SAM levels or its regulation during the 
transition between naïve and primed human embryonic states. Recent derivation of naïve 
human ESCs allows a deeper analysis of the human naïve to primed transition6–12. These 
studies have already revealed that the epigenetic landscape changes from the naïve to primed 
state through increased H3K27me3 repressive methylation marks. However, the regulation 
of this process or the metabolomics of this transition have not been dissected.
We now show that the upregulation of H3K27me3 repressive epigenetic marks during naïve 
to primed hESC transition is controlled by the metabolic enzyme, NNMT. Knockdown of 
NNMT in naïve hESCs increased H3K27me3 repressive marks in developmental as well as 
key metabolic genes that regulate the metabolic switch in naïve to primed transition. 
CRISPR-Cas9 based NNMT KO naïve hESC lines show upregulation of SAM, H3K27me3 
marks, HIF activation, Wnt repression and a general gene expression shift towards primed 
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stage. These data show that NNMT consumes SAM in naïve cells, making it unavailable for 
histone methylation. Histone methylation further regulates the key signaling pathways 
important for the metabolic changes that are necessary for early human development.
RESULTS
A dramatic metabolic switch occurs in mouse ESCs between pre-implantation (naïve) and 
post-implantation (primed) state20. Human naïve counterpart has been recently toggled or 
derived from embryos. Principal component analysis (PCA) of the expression signatures of 
these new cell types confirmed that all derived human naïve hESCs are in a significantly 
earlier stage than primed hESCs6,8–10,23(Fig.1A–B, Suppl.Fig.1A–C, Suppl.Table.1A). To 
assess the metabolic profiles of the human naïve and primed hESCs, we analyzed the cells’ 
oxygen consumption rates (OCR) using a SeaHorse extracellular flux analyzer. As seen 
previously in mouse ESCs20, we detected an increase in oxygen consumption rate after 
FCCP injection in the newly derived naïve hESCs (Elf112; WIN-110) while little increase 
was observed in primed hESCs (H1, H7) or cells transitioning to primed state (Elf1 AF, 
WIN1 AF) (Fig.1C–F, Suppl.Fig.1E–I). Likewise, cells “toggled” back to a more naïve state 
(H1 2iF12, H1 4iLIF) showed increased OCR in response to FCCP to a level similar to 
mESCs (Fig1A,C–D, Suppl.Fig1G,J–K). These results indicate that the primed hESCs have 
a lower mitochondrial respiration capacity than naïve hESCs.
The higher mitochondrial capacity of naïve hESCs (Elf1) reflects neither more mature 
mitochondria12, nor an increase in mitochondrial DNA (mtDNA) copy number compared to 
primed hESCs (ElfAF, H7, H1) (Fig.1H, Fig.1L–M). Further, no obvious increase in mtDNA 
mutation frequency was detected in primed compared to naïve hESCs (Fig.1I, Suppl.Fig.
1N–O), suggesting that reduction of oxidative respiration in primed hESCs is not caused by 
a deteriorating mitochondrial genome. However, consistent with the mouse data, RNA-seq 
data from our study and microarray or RNA-seq data from other studies3,6,8–10 showed that 
expression of most mitochondrial electron transport chain complex IV- Cytochrome c 
oxidase (COX) genes is significantly downregulated in the primed state compared to the 
naïve state (Fig.1G, Suppl.Table1B–D). Also, consistent with the mouse data20, HIF1α is 
stabilized in primed but not in naïve hESCs (Fig.1J), correlating with a significant change in 
expression of prolyl hydroxylase domain-containing protein 2, PHD2 (EGLN1), the primary 
regulator of HIF1α steady state levels24,25 (Suppl.Table.1B). Further support for HIF1α 
stabilization and activity at the primed state comes from our proteomic analysis revealing a 
significant increase in the protein expression of HIF targets, Ldha and Jarid2 at primed 
hESC state (Elf1 AF compared to Elf1; Fig.1K–L; Suppl.Table.1E; Suppl.Fig.1P, validation 
in Fig.1M).
Differential metabolites between naïve and primed embryonic stem cells
To search for critical metabolites that control the metabolic transitions between naïve and 
primed mouse and human ESCs, we performed metabolic profiling using GC-TOF, LC-
QTOF and LC-QQQ mass spectrometry (MS) analysis (Fig.2A; Suppl.Table.1F–L).
PCA of the metabolite data reveals a difference in metabolite profiles between naïve and 
primed cells, regardless of species (Fig.2B–F, Suppl.Fig.2). Multiple naïve and primed cell 
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lines from human and mouse separated clearly by naïve vs. primed state based on the PCA 
plot of GC metabolomics data (Fig.2B, D–F; Suppl.Fig.2A–C). Stearic acid and cholesterol 
are the metabolites that contribute the most to the separation within the first PC, indicating 
that when ESCs transition from naïve to primed state, a major switch occurs in the lipid 
metabolism. A similar trend of naïve and primed ESC separation is observed in PCA plots of 
the LC metabolomics data (Fig.2C, Suppl.Fig2D). However, H1 2iF, which is a primed cell 
line “toggled” towards the naïve state, and Elf1, the naïve hESC line, clustered midway 
between mouse naïve cell line (R1) and primed cell lines (R1AF, EpiSC, Elf1AF, H7 and 
H1) in LC analysis, suggesting that H1 2iF and Elf1 have not reached the same naïve state as 
observed in mouse, with respect to lipid signature (Fig.2C; Fig.2D).
In addition, targeted analysis of metabolites was performed using LC-QQQ-MS with naïve 
Elf1 and primed H1 hESCs (Fig.2G, Suppl.Table.1H–I) and using GC-TOF with naive Elf1 
and primed ElfAF (Suppl.Fig.2B, Suppl.Table.1J). Metabolites upregulated in the primed 
state include fructose(1,6/2,6)-bisphosphate (F16BP or F26BP), lactate, methionine, 
nicotinamide and kynurenine (Fig.2F–G; Suppl.Fig.2B). Upregulation of F16BP is in 
concord with highly active glycolysis, however, phosphoenolpyruvate (PEP), a downstream 
metabolite of F16BP, does not increase in primed hESCs (Fig.2H–I). Intermediates prior to 
PEP can be conserved for biosynthetic purposes: 3-phosphoglycerate (3PG) can be diverted 
to serine and glycine synthesis, which can supply one-carbon units to multiple methylation 
reactions; dihydroxyacetone phosphate (DHAP) can be converted to glycerol, which serves 
as the backbone of glycerolipids. Therefore we tested potential changes in lipid and fatty 
acid metabolism and amino acid pathways (Fig.2H).
Differential Fatty Acid metabolism in Naïve and Primed ESCs
Further lipid analysis was performed using a LC-QTOF instrument on naïve Elf1 and 
primed H1 cells (Suppl.Table.1K) as well as non-targeted LC-QTOF analysis on Elf1, Elf 
AF, R1 and mEpi ESCs (Suppl.Table.1L). For 119 lipidomic features with identified 
molecular formulae and structures, lipids more abundant in H1 have higher numbers of 
carbons (Wilcoxon rank sum test p-value 4.30e-4, Fig.3A). For 320 features with just 
identified mass, lipids more abundant in H1 are heavier (p-value=1.66e-10, Fig.3B). Non-
targeted LC-QTOF also showed that lipids more abundant in mEpi than in R1 have a 
significantly higher number of carbons (p-value=0.012, Suppl. Fig.3G). When sorting based 
on level of unsaturation lipids more abundant in primed R1AF have a higher number of 
double bonds than lipids more abundant in naïve R1 (p-value=0.044, Fig.3C), which can 
also be observed in primed Elf1 AF compared to naïve Elf1 (p-value=7.35e-5, Suppl.Fig.
3F).
In concordance with the significant increase in long carbon chain lipids observed in primed 
mouse and human ESCs, we also detected a significant increase in accumulation of lipid 
droplets in the primed state, as observed by Oil Red O and BODIPY staining (Fig.3D–E, 
Suppl.Fig.3A–B). These data indicate an increased synthesis and-or decreased beta-
oxidation in primed cells. Interestingly, several of the enzymes involved in fatty acid 
transport into the mitochondria and fatty acid beta-oxidation are significantly downregulated 
in primed human ESCs, as well as in mouse in vivo post-implantation state (Suppl.Fig3H–I). 
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Carnitine acyltransferase 1 (CPT1) transfers long chain acyl groups to carnitine, facilitating 
the initial step in acyl transfer to the mitochondrial matrix. Interestingly, the rate limiting 
fatty acid transporter CPT1A is downregulated in both mouse in vivo post-implantation and 
human primed ESC state compared to all analyzed naïve states (Fig.3F). The decrease in 
CPT1A expression in the primed state could be due to increased H3K27me3 and decreased 
H3K4me3 and H3K27ac marks observed in CPT1A promoter in primed hESCs6,8,12 
(Fig3G; Suppl.Fig3C). Several of the miRNAs predicted to target CPT1A and other enzymes 
involved in beta-oxidation are up-regulated in primed hESCs (e.g., miR-9, miR-33a-3p, Fig.
3H; Suppl.Table.1M). Moreover, microRNAs predicted by Targetscan and miRTarBase to 
target enzymes involved in fatty acid synthesis were downregulated in primed cells (e.g., 
miR-10a and miR-193, Fig.3H). Concomitantly, key fatty acid synthesis genes were up in 
primed H1 hESCs compared to naïve Elf1 state (SLC25A1, ACLY, ACACA, FASN, and 
SREBP-1c; Suppl.Fig3D). We further validated some of the miRNAs by qPCR analysis and 
showed that miR-9, predicted to target CPT1A, was upregulated, while miR-10a, predicted 
to target SREBP-1c (a regulator of fatty acid and cholesterol synthesis), was downregulated 
in the human primed state (Fig.3I).
To test the level of fatty acid beta-oxidation in naïve and primed human and mouse ESCs, 
we performed a palmitate-oxidation assay in the Seahorse metabolic flux analyzer26. 
Importantly, both mouse and human naïve ESCs were capable of utilizing palmitate as an 
energy source, while primed mouse or human ESCs were not (Fig.3J–L; Suppl.Fig.3E). This 
result suggests that primed human and mouse ESCs are not capable of significant beta-
oxidation and, in combination with increased fatty acid synthesis, may explain the 
accumulation of lipids observed in this state (Fig.3D–E, Suppl.Fig.3A–B).
Differential amino acid metabolism in naïve and primed ESCs
In addition to glycolysis and fatty acid metabolism, primed cells show changes in amino 
acid metabolism pathways. In primed vs. naïve hESCs we observed a large enrichment of 
the tryptophan degradation product kynurenine, which can act as a ligand for the nuclear 
receptor AHR27 (Fig.4A,C). Interestingly, tryptophan is shown to be critical for primed 
hESCs growth22. Accordingly, RNAseq and qPCR data show a large increase of the 
tryptophan metabolizing enzyme IDO1 in primed hESCs compared to naïve hESC and in 
vivo 8 cell human embryo23 (Fig.1B, Fig.4BE,; Suppl.Fig.4A). IDO1 levels quickly drop 
during differentiation, indicating a specific function for IDO1 in primed state28 (Suppl.Fig.
4B–C, Suppl.Table.1N, 12,70).
Interestingly, a strong upregulation of 1-methyl-nicotinamide (1-MNA), a product of 
Nicotinamide N-methyltransferase (NNMT) activity was observed in all naïve compared to 
primed hESC (Fig.4G). Methionine and nicotinamide downregulation along with 1-MNA 
upregulation in the naïve state correlates with upregulation of NNMT, shown previously to 
create a metabolic methyl sink, thereby promoting epigenetic remodeling in cancer28 (Fig.
4D–G, Suppl.Fig.4G). Primed hESCs show an increase in SAM levels compared to the naïve 
state (Fig.4H; Suppl.Fig4H; Suppl.Table.1O). The increase in SAM correlates with the sharp 
decrease in NNMT enzyme levels observed in primed hESCs6,8,11 (Fig.4H,E–F), suggesting 
that SAM levels may be reduced in the naïve state by high NNMT activity. Further, 
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significant expression changes of NNMT among various tissues reveal that NNMT is 
dynamically regulated during development and suggest that NNMT might act as regulator of 
SAM levels also in a developmental context, not only in cancer29 (Suppl.Fig.4D–F, 
Suppl.Table.1N). Accordingly, we show that high levels of SAM induce a primed-like 
metabolic profile in naïve hESCs while overexpression of NNMT, but not the mutated form 
of NNMT delays the naïve to primed hESC metabolic switch (Fig.4H–K, Suppl.Fig.4I).
NNMT regulates repressive histone modifications
Reduction of NNMT levels during the naïve to primed transition correlates with a significant 
increase in SAM levels and in H3K27me3 histone methylation marks in 648 
developmentally regulated genes6,8,10,12 (Fig.5A). Moreover, Western blot analysis revealed 
an overall increase of H3K27me3 and H3K9me3 marks in primed hESCs compared to naïve 
hESCs, while the H3K9 and H3K14 acetylation marks remained unchanged (Fig.5B, 
Suppl.Fig.5H). ChIP-seq analysis of other marks (H3K4me1, H3K4me3 and H3K27ac) did 
not show significant change between primed and naïve hESCs6,8 (Suppl.Fig.5A–G). RNA-
seq analysis of histone methyltransferases and histone demethylases involved in H3K27 and 
H3K9 methyl marks did not show changes in expression levels that could explain the 
significant increase in repressive methylation marks observed at the primed state (Suppl.Fig.
5I–J). Furthermore, we showed by Western analysis that the protein levels of the polycomb 
repressive complex 2 (PRC2) regulator, EED, are not increased in primed state compared to 
naïve state (Fig.5B).
Overexpression of NNMT in primed cells reduced H3K27me3 marks (Suppl.Fig.4I). The 
direct reduction of NNMT levels in naïve hESCs significantly reduced the enzymatic 
product, 1-MNA, reduced naïve hESC enriched microRNAs and increased H3K27me3 and 
H3K9me3 marks, as analyzed by Western blots, while H3K9 and H3K14 acetylation marks 
did not change (Fig.5C–D,Suppl.Fig.5K–L). RNA-seq analysis of NNMT knockdown 
identified a significant overlap between genes changed in NNMT KD and naïve to primed 
transition (Fig.5E). In particular, the most significant overlap is observed between genes up-
regulated by NNMT knockdown and genes expressed higher in Elf AF vs. Elf1. Therefore, 
based on transcriptome signatures, NNMT knockdown samples do not only show increased 
repressive H3K27me3 marks but are also moving towards the primed state.
To analyze the early NNMT responsive genes for H3K27me3 marks, we altered the NNMT 
regulator, LIF-STAT pathway. In naïve hESCs LIF activates STAT330. Activated STAT is 
previously shown to bind NNMT promoter and activate its transcription31. H1 toggled to 
more naïve state using 2iF12 without external LIF addition also has high level of NNMT 
(Fig.4F) and activated LIF-STAT pathway, suggesting that LIF pathway is endogenously 
activated in the naïve hESC state (Suppl.Fig.5M). We show that treating naïve hESCs with a 
STAT3 inhibitor affects NNMT expression and the repressive histone methylation pattern. 
qPCR analysis showed a reduction of NNMT expression on Elf1 cells as early as 6h after 
STAT3 inhibitor addition (Suppl.Fig.5N).Importantly, reduction of NNMT in naïve hESCs 
by STAT3 inhibitor also increased H3K27me3 and H3K9me3 marks, as shown by Western 
blot analysis (Fig.5F). We characterized H3K27me3 in naïve hESCs by ChIP-seq analysis 
and observed a significant increase in H3K27me3 marks at promoters after 6h STAT3 
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inhibitor treatment (Fig.5G; Suppl.Table.1P–Q). Interestingly, over 25% (313 genes) of 
genes with primed-enriched H3K27me3 marks already showed increased H3K27me3 marks 
after 6 hour STAT3 inhibitor treatment (Fig.5H; Suppl.Table1R). Windowed heatmap and 
average profile of ChIP-seq signal revealed a dramatic increase in H3K27me3 marks close 
to the transcription start site of these 313 genes in the naïve to primed transition as well as 
after 6h STAT3 inhibitor treatment5,9 (Fig.5I–J). Among these genes are components of the 
WNT pathway and regulators of HIF (Fig.5H, Suppl.Table1R).
The majority of Wnt ligands and target genes are downregulated in primed compared to 
naïve hESCs, suggesting that the Wnt pathway might be inactivated during the naïve to 
primed transition (Fig.6A, Suppl.Fig.6A–D; Fig.1B, 1L, Vime32). Previous studies have 
revealed that in human and mouse primed ESCs the Wnt pathway is not active and forced 
activation of the pathway leads to differentiation33,34. We now show using a Wnt-pathway 
activity reporter33 that while the reporter is not activated in primed hESCs, strong activation 
is observed in naïve hESCs (Fig.6B, Suppl.Fig.6F). We furthermore show that the Wnt-
activity in naïve hESCs is dependent on β-catenin since siRNA(β-cat) or XAV939 treatment 
dramatically downregulated the reporter activity (Fig.6C, Suppl.Fig.6E). In addition, the 
Wnt ligand is produced by the naïve hESCs since IWP2, an inhibitor that represses Wnt 
palmitylation also represses the reporter activity in naïve cells (Fig.6C). Inhibition of Wnt in 
naïve hESCs reduces expression of the naïve hESC enriched markers, NNMT and 
microRNA miR-37212 and accelerates the transition toward the primed metabolic state (Fig.
6D–F, Suppl.Fig.6G). These data reveal that the robust Wnt activity in naïve hESCs is 
among the earliest responders to the repressive H3K27me3 marks during naïve to primed 
hESC transition.
A significant increase of H3K27me3 marks was observed in the metabolic gene, prolyl 
hydroxylase 2 (EGLN1), ECHS1, HIGD1 and miR-193 (Fig.5H, Fig.7A) promoters in the 
primed state as well as in STAT3 inhibitor treated Elf1 cells, vs. naïve state (Suppl.Table.
1R). The increased repressive H3K27me3 mark in EGLN1 promoter correlated with the 
observed reduced gene expression in the primed state (Fig.7A). Since EGLN1 induces 
HIF1α VHL and ubiquitination-dependent degradation, its repression in the primed state 
(Fig.7A) could cause HIF1α stabilization in primed hESC stage (Fig.7B; Fig.1J). 
Furthermore, ectopic HIF1α stabilization accelerates primed hESC markers (Suppl.Fig.7A–
C). To test whether HIF1α KO affects naïve to primed transition in hESCs, we generated 
CRISPR-Cas9 based HIF1α KO lines and analyzed their capacity to develop from pre- to 
post-implantation stage in human development (Fig.7C–F, Suppl.Fig.7D). Importantly, the 
gene expression analysis revealed that naïve markers were upregulated and primed markers 
downregulated, suggesting that HIF1α KO naïve hESCs are not capable of transitioning to 
primed stage (Fig.7G). Furthermore, Seahorse flux analysis showed that HIF1α KO hESCs 
do not display OCR reduction, suggestion that they are defective in metabolic switch 
normally observed in naïve to primed hESC transition (Fig.7H, Suppl.Fig.7E). These data 
show that HIF1α is required for naïve to primed hESC transition.
To validate the NNMT based regulation of Wnt and HIF pathways in naïve to primed 
transition (Fig.5H) we generated CRISPR-Cas9 based NNMT KO mutant lines that lack 
NNMT enzymatic activity as shown by lack of 1-MNA production and increase in SAM 
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levels (Fig.8A–D; Suppl.Fig.8A–D8G,; Fig.4G). As observed with NNMT KD experiments 
(Fig.5D), NNMT KO lines showed significant increase in H3K27me3 marks (Fig.8E). This 
epigenetic modification was accompanied with dramatic stabilization of HIF1α protein and 
downregulation of naïve hESC marker DNMT3L (Fig.8E–F). Furthermore, genome wide 
RNA sequencing results revealed that NNMT KO line 7-2-1 shows upregulation of HIF 
pathway genes, downregulation of Wnt pathway (Fig.8G) and a genome wide gene 
expression signature indicative of a general shift towards primed stage, even in the presence 
of primed stage inhibitors (2iLIF) (Fig.8H–I, Suppl.Fig.8E–F8H,). Downregulation was also 
observed among a significant fraction of the 313 genes with increased repressive H3K27me3 
marks in primed stage and after STAT3 inhibitor treatment (hypergeometric test p-value 
<0.0036). In summary, these data show that NNMT affects naïve to primed hESC transition 
through epigenetic alterations that repress Wnt pathway and activate HIF pathway.
DISCUSSION
We show that human naïve and primed ESCs display distinct metabolic profiles and the 
switching between these metabolic states is regulated by NNMT, which controls the amount 
of SAM available for PRC2 dependent H3K27me3 histone methylation. Repressive histone 
methylation then controls the primed hESC specific metabolism through the Wnt and HIF 
pathways (Fig.8J). The naïve to primed hESC transition shows a reduction in Wnt signaling, 
electron transport chain activity, and fatty acid beta-oxidation and increase in mechanisms 
involved in lipid biosynthesis and HIF1α stabilization. In naïve hESCs NNMT and its 
enzymatic product 1-MNA are highly upregulated, while the substrates, nicotinamide and 
SAM are downregulated, correlating with reduced H3K27me3 marks. Inhibition of the 
NNMT regulator, STAT3, in naïve hESCs increases H3K27me3 repressive marks in 
developmental and metabolic genes, including Wnt signaling and the HIF1 repressor, prolyl 
hydroxylase EGLN1. Further validations using Wnt pathway inhibitors reveal Wnt activity 
critical for naïve state. HIF1α KO mutant line generated by CRISPR-Cas9 system is 
incapable of the naïve to primed metabolic and fate switch, showing that HIF1α is required 
for naïve to primed hESC transition. NNMT KO naïve hESC lines show increased 
H3K27me3 marks, HIF1α stabilization and Wnt ligand reduction, all indications of 
transition towards primed stage, even in the presence of naïve state stabilizers (MEK and 
GSK3 inhibitors and LIF). These data show that NNMT consumes SAM in naïve cells, 
making it unavailable for histone methylation that represses Wnt pathway and electron 
transport chain activity and activates HIF pathway and lipid synthesis, facilitating the 
metabolic switch in the naïve to primed hESC transition (Fig.8J). Therefore, differential 
metabolites between pluripotent states control epigenetic dynamics and signaling.
Primed ESCs are dependent on glycolysis14,17,35–38. We now show that while early 
glycolysis metabolites are upregulated, the downstream metabolites are downregulated in 
primed state hESCs, suggesting that metabolites are being channeled off to increase the 
amount of glycerol backbone available for biosynthesis of lipids in primed cells, or for the 
one-carbon cycle for methylation reactions by SAM. SAM can also be regulated by NNMT, 
whose enzymatic product, 1-MNA is dramatically increased in naïve vs primed hESC. Since 
NNMT is considered to create a methyl-sink28, reduction of NNMT in primed hESC can 
make SAM available as a substrate for DNA and histone methylation. We show that a 
Sperber et al. Page 8
Nat Cell Biol. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
difference in SAM levels between naïve and primed hESCs correlates with dramatic changes 
in H3K27me3 marks6,8,10–12 and reveal NNMT as a key regulator of these changes. while 
previous studies have shown SAM dependent regulation of histone methylation in stable 
primed hESCs, the effect was mainly observed in H3K4me3, not in H3K27me3 marks22. It 
is plausible that H3K27me3 marks, once established are less dynamic in primed hESCs than 
H3K4me3 marks39.
While H3K27me3 marks are reduced in naïve compared to primed hESCs, the enzymes 
required for this methylation (EZH2 and EED) are not downregulated. We now show that 
high NNMT activity in naïve hESCs sequesters the methylation substrate, SAM, thereby 
repressing H3K27me3 marks. Furthermore the PRC2 recruiting protein Jarid2 is upregulated 
in primed hESCs compared to naïve, which may give further specificity to PRC2 action in 
naïve to primed hESC transition40,41(Fig.1B, 1L–M, 8J).
In this study we show a direct impact of SAM levels and NNMT function on histone marks 
in naïve hESC,, revealing that changes in the metabolic profile of hESCs shape the 
epigenetic landscape during development. While previous studies have revealed the 
importance of Wnt and HIF pathways in naïve or primed pluripotent stem cells34,38,42–44, 
we now show that these pathways are regulated by metabolite levels. We propose that the 
availability of SAM triggers the cascade by activating PRC2 and thereby increasing 
repressive H3K27me3 epigenetic marks in the promoters of key regulators of naïve to 
primed transition, HIF repressor and Wnt ligands (Fig.8J). These studies pave the way for 
further understanding and utilization of metabolite specific molecular mechanisms for cell 
fate changes in general.
MATERIALS AND METHODS
Culture of primed and naïve embryonic stem cells
Primed human ESCs [H1 (WA-01, WiCell) and H7 (WA-07, WiCell)] and naïve hESCs 
[Elf-1(NIHhESC-12–0156, University of Washington), WIN1(NIHhESC-14–0299, MIT)] 
and LIS18 (Weizmann Institute of Science) were cultured as previously described10,12. 
Briefly, the cells were cultured on a feeder layer of irradiated primary mouse embryonic 
fibroblasts (MEF) in hESC media (Supplemental table 3). One passage prior to the 
experiments, the cells were transferred to growth factor reduced Matrigel (Becton 
Dickinson, Moutainview, CA) in MEF conditioned media (CM). Reverse toggling of H1 and 
H7 cells was performed using supplemented media (Supplemental table 3). H1 cells were 
pushed toward a more naïve state by culture in 4iLIF (modified from Gafni et al: 1µM GSK3 
inhibitor (CHIR99021), 1µM of MEK inhibitor (PD0325901), 5µM JNK inhibitor 
(SP600125), 2µM p38 inhibitor (BIRB796), 10ng/mL human LIF, 5ng/mL IGF and 
10ng/mL bFGF for 3 passages (Suppl.Fig.1D). In addition, human naïve cells (Elf1 and 
WIN1) were pushed toward a more primed state by culturing them in either TeSR1 
(STEMCELL technologies), or bFGF (10ng/mL) with or without Activin A (10ng/mL) for 3 
passages (Elf1 AF, WIN1 AF, WIN1 F, WIN1 TeSR). Mouse ESCs (R1, EpiSC, R1 AF) 
were cultured as described in Supplemental table 3. All cells were grown at 37 degres, 
5%CO2 and 5% O2. Cells have been karyotyped by Diagnostic Cytogenetics,inc. and were 
tested for mycoplasma detection using MycoAlert detection kit (Lonza).
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OCR and ECAR measurement using Seahorse Cellular Flux assays
Naïve and primed ESCs were seeded onto 96-well Seahorse plates pre-coated with Matrigel 
at 25×104 or 40×104 cells/well. Culture media were exchanged for base media (unbuffered 
DMEM (Sigma D5030) supplemented with sodium pyruvate (Gibco, 1mM) and with 25mM 
glucose (for MitoStress assay), 25mM glucose and 50µM carnitine (for palmitate assay), or 
2mM glutamine (for glucose stress assay) 1 h prior to the assay. Substrates and selective 
inhibitors were injected during the measurements to achieve final concentrations of glucose 
(2.5mM), 4-(trifluoromethoxy)phenylhydrazone (FCCP, 300nM-500nM), oligomycin (2.5 
µM), antimycin (2.5µM), rotenone (2.5µM), palmitate (50µM in BSA), BSA and ETO 
(50µM). The OCR and ECAR values were normalized to the number of cells present in each 
well, quantified by the Hoechst staining (HO33342; Sigma-Aldrich). Changes in OCR and 
ECAR in response to substrates and inhibitors addition were defined as the maximal change 
after the chemical injection compared to the last OCR value before the injection.
Mitochondrial DNA mutation frequency and copy number analysis
The DNA of Elf1 and H7 cells was isolated using DNAzol (Invitrogen). TaqMan primers 
were used to quantify mitochondrial and genomic DNA (Suppl.Table.2). The ratio of 
mtDNA to genomic DNA was determined using a standard curve for each primer. Each 
reaction contained 2 ng of DNA extract, 1x TaqMan Universal PCR Master Mix No 
AmpErase UNG, 500nM of each primer, and 200nM of the TaqMan probe. Using 7300 real 
time PCR system (Applied Biosystems), the reactions were amplified by incubation at 50°C 
for 2 minutes, 95°C for 10 minutes, and then 40 cycles of 15 seconds at 95°C followed by 1 
minute at 60°C where the intensity of fluorescence was measured. Naïve hESCs (Elf1) and 
primed hESCs (H1 and Elf1 AF) cells were grown in triplicate for mutation analysis. Elf1 
were analyzed between passage 19 and 23, Elf1AF were analyzed at passage 25 and H1 at 
passage 65All lines were grown on Matrigel for the last passage prior to analysis.
DNA was isolated from hESCs with the DNeasy Blood and Tissue Kit (QIAGEN). Rare 
mutation-bearing molecules were selectively enriched through endonucleolytic destruction 
of wild-type target sites by sequential additions of TaqI (New England Biolabs). Complete 
cleavage of wild-type TaqI sites was verified by PCR followed by restriction digest and gel 
electrophoresis. Reaction droplets were prepared as described previously51, with primers 
and probe sets specific to each target region (Supplementary Table 2). Fragments for point 
mutation detection and mtDNA copy number measurement were amplified as follows: 95°C 
for 10 min, followed by 40 cycles of 94°C for 30 s, and 60°C for 1 min. For digital deletion 
detection, thermal cycling was as follows: 95°C for 10 min, followed by 50 cycles of 94°C 
for 30 s, and 63.5°C for 2 min. The thermally cycled droplets were analyzed by flow 
cytometry in a QX100™ Droplet Digital™ Reader (Bio-Rad) for fluorescence analysis and 
quantification of mutation frequencies and mtDNA copy number, as described elsewhere51
Proteomics
Naïve hESCs (Elf1 2iLIF) and primed hESCs (Elf1 AF) were washed in 1xPBS and flash 
frozen. Cell pellets were lysed in 1M urea, 50mM ammonium bicarbonate, pH 7.8, and 
heated to 50°C for 20min. Normalized quantities of protein were reduced, alkylated, and 
digested overnight with trypsin. The resulting peptides were desalted on Waters Sep-Pak 
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C18 cartridges. Peptides were measured by nano-LC-MS/MS on a Thermo Scientific Fusion 
Orbitrap. Peptides were separated by reverse phase chromatography in a 180min gradient 
(1–45% acetonitrile). The Fusion was operated in data-dependent mode with the following 
settings: 60000 resolution, 400–1600 m/z full scan, Top Speed 3 seconds, and an 1.8 m/z 
isolation window. Identification and label free quantification of peptides was done with 
MaxQuant 1.552 using a 1% false discovery rate (FDR) against the human Swiss-Prot/
TrEMB database downloaded from Uniprot on October 11th, 2013. We analyzed two 
biological and three technical replicates per condition. Proteins that were significantly 
regulated between conditions were identified using a permutation-based t-test (S1, FDR 5%) 
in Perseus 1.4.1.3.
Non-targeted GC-TOF and LC-QTOF analysis for metabolites in mouse and 
human ESCs—For the first set of experiments (Fig.2B–F) 5–20 million cells per replicate 
(grown on “ghost”: irradiated MEFs lysed using a detergent solution 0.5% Triton and 
0.034% (v/v) NH4OH (Sigma-Aldrich) to retain their extracellular matrix) were scraped in 
PBS, pelleted in 6 replicates per condition, frozen at −80 °C. For the first set of experiments 
cells were thawed on ice and mixed with 2mL of ice-cold degassed acetonitrile then 
vortexed for 20 sec and sonicated for 5 min.1mL material was taken and centrifuged for 
5min at 14,000 rcf. Supernatant was divided into a 500µL (GC-TOF) and a 250µL (LC-
QTOF) aliquot. Lyophilized aliquots were resuspended in 500µL of 1:1 acetonitrile:H2O and 
centrifuged. Supernatants were lyophilized until analysis. For the second set of experiments 
cells were thawed on ice and extracted as previously reported53. The upper layer was used 
for LC/MS analysis and bottom layer used for GC/MS analysis, both layers were evaporated 
to dryness.
Mass spectrometry-based untargeted metabolomics—Primary metabolites were 
derivatized in 40ug/mL methoxyamine/pyridine and subsequently trimethylsilylated. GC-
TOF MS analysis was performed as previously described54,55 using a Leco Pegasus IV time 
of flight MS coupled to an Agilent 6890 GC equipped with a 30m long 0.25mm id Rtx5Sil-
MS column and a Gerstel MPS2 automatic liner exchange system. Data were processed by 
ChromaTOF and BinBase filtering for metabolite identifications54.
LC-QTOF MS was used for analysis of complex lipids. For the first set of experiments, 
lyophilized material was redissolved in 100µL initial LC gradient solvent and analyzed 
within 24 hrs. HILIC and Reversed Phase LC-QTOF analysis and data processing was 
performed as previously described55 using an Agilent 1200 series HPLC equipped with 
either Agilent Zorbax Eclipse Plus C18 2.1×150mm column for Reversed Phase or a Waters 
1.7µm Acquity BEH HILIC 2.1×150mm column. LC eluents were analyzed with an Agilent 
6530 accurate mass Q-TOF mass spectrometer. For the second set of experiments the lipid 
extracted phase was analyzed as previously described53. Method blanks and human pooled 
plasma samples were used as QC controls. MZmine 2.10 was used to process the raw data 
and metabolites were reported when present in 50% of the samples in each group. 
Annotations were made based on in house accurate mass and retention time library created 
using LipidBlast, described previously54,56.
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Multivariate Analysis of Primed vs Naïve Metabolomes
Metabolite measurements of known and unknown GC metabolites and known lipid 
metabolites (from ESI(+) and ESI(−) modes) were submitted using R to DeviumWeb (v 
0.3.2)53 and normalized using unit norm normalization. O-PLS-DA, a multivariate 
classification model, was used to identify differences between primed and naïve human and 
mouse cells. Robust model performance statistics were generated by 100 rounds of Monte 
Carlo cross validation using training and testing compared to the permuted model (random 
chance).
LC-QTOF for Elf1 and H1 hESCs
For lipid extraction Elf1 and H1 cells were grown on matrigel for one passage. Cells were 
washed with PBS and 37 °C deionized water followed by the addition of 0.5ml of a −75 °C 
solution of internal standards54 and incubation on dry ice for 15 min. Cells were scraped into 
eppendorf tubes and 1ml of chloroform was added, followed by 15 min incubation on dry 
ice and spun for 5 min at 4 °C at 18000 rcf, after which the lower phase was collected and 
stored at −80 °C.
LC-QTOF-MS experiments were performed using an Agilent 1200 SL LC system coupled 
online with an Agilent 6520 Q-TOF mass spectrometer. Each sample (4 µL for positive ESI 
ionization, 8 µL for negative ESI ionization) was injected onto an Agilent Zorbax 300 SB-
C8 column, which was heated to 50 °C.
Targeted LC-QQQ-MS analysis for water soluble metabolites
Targeted LC-QQQ-MS analysis was performed to detect a different set of water soluble 
metabolites to complement the other non-targeted mass spec experiments. Elf1 and H1 cells 
were grown on matrigel for one passage, washed with PBS and ice cold deionized water 
followed by the addition of a −75 °C 0.75 mL 9:1 methanol:chloroform solution. The plates 
were incubated on dry ice for 15 min before scraping into eppendorf tubes, which were spun 
at 18000 rcf for 5 min at 4 °C. All soluble extract was transferred into a new eppendorf tube 
and vacuum dried. Samples were stored in −80°C.
Chromatography conditions: dried samples were reconstituted in 200 µL 5 mM ammonium 
acetate in 40% water/60% acetonitrile + 0.2% acetic acid, and filtered through 0.45 µm 
PVDF filters (Phenomenex, Torrance, CA) prior to LC-MS analysis. LC-MS/MS was 
performed using an Agilent 1260 LC AB-Sciex 5500 QQQ MS. Both chromatographic 
separations were performed in HILIC mode on two SeQuant ZIC-cHILIC columns. The 
mobile phase was composed of Solvents A (5 mM ammonium acetate in 90%H2O/ 10% 
acetonitrile + 0.2% acetic acid) and B (5 mM ammonium acetate in 90%acetonitrile/ 10% 
H2O + 0.2% acetic acid). The chromatographic separation, MS ionization and data 
acquisition was performed using an AB Sciex QTrap 5500 mass spectrometer equipped with 
electrospray ionization (ESI) source. The instrument was controlled by Analyst 1.5 software. 
Targeted data acquisition was performed in multiple-reaction-monitoring (MRM) mode. The 
extracted MRM peaks were integrated using MultiQuant 2.1 software
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Targeted HILIC-QTOF mass spectrometry metabolite quantifications of methionine 
metabolites
Cells were grown on matrigel for one passage, scraped and washed with PBS at room 
temperature, pelleted and flash frozen in liquid nitrogen. Samples were extracted by adding 
1mL cold 3:1 cold methanol:water to the cell pellet, vortexed, placed at −20°C for 30 
minutes, and centrifuged for 10 minutes at 14000 rcf. The supernatant was transferred then 
centrifuged again, then supernatant was evaporated to dryness. Samples were re-suspended 
in 80:20 acetonitrile:water containing Val-Try-Val. Standard curve dilutions for 
quantifications were prepared using mixture of 1-methylnicotinamide HCl (1-MNA), S-
methyl-5’-thioadenosine (MTA), S-adenosyl methionine (SAM), S-adenosyl homocysteine 
(SAH), Methionine, Kynurenine and Tryptophan (Sigma).
Hydrophilic interaction chromatography (HILIC) analysis of standard curve and samples 
was performed using an Agilent 1290 Infinity Ultrahigh Pressure Liquid Chromatography 
stack equipped with an auto-sampler (4°C) using 5 µL injections into an Acquity UPLC 
BEH Amide column (Waters Corporation). Mobile phases were prepared with 10mM 
ammonium formate and 0.125% formic acid in either 100% LCMS grade water for mobile 
phase A or 95:5 acetonitrile:water for mobile phase B. Metabolites were detected and 
quantified by an Agilent 6530 accurate mass quadrupole time-of-flight (QTOF) mass 
spectrometer with a jet stream ESI source in positive ion mode. Mass calibration was 
maintained by constant reference ion infusion, with MS data collected at 4 spectra/s. Data 
files were analyzed using Agilent Mass Hunter TOF Quantitative Analysis software. Peak 
filtering was performed manually to eliminate peaks with a signal to noise ratio of less than 
3. Retention times and major adducts for each compound are as follows: 1-MNA (m/z 
137.0715) 6.345 min, MTA (m/z 297.0896) 2.583 min M+H, tryptophan (m/z 204.0899) 
6.904 min M+H, kynurenine (m/z 208.0848) 6.971 min. M+H & M+Na, methionine (m/z 
149.0511) 7.493 min M+H & M+2Na+H, SAH (m/z 384.1216) 8.810 min M+H, SAM (m/z 
399.1451) 9.768 min. Metabolites at undetectable levels and metabolites whose levels 
saturated the system were given the lowest and highest detectable values respectively in 
subsequent analysis
Metabolite levels were sum-normalized for each sample using the methionine metabolite 
values (methionine, nicotinamide, MTA, 1-MNA, SAM and SAH). P-values were calculated 
using a 1-tailed t-test.
Transcriptomic data analysis
RNA-seq data processing was performed according to Takashima et al9. Raw RNA-seq reads 
from this study and 3 other studies (Chan et al6) and Takashima et al9, Yan et al23) were 
aligned to hg19/GRCh37 with STAR aligner57. Transcript quantification was performed 
with htseq-count from HTSeq package58 using GENCODE v15. Differential expression 
analysis was performed with DESeq after filtering out genes whose total read count across 
samples are below the 40th quantile of all genes.
Size factors used to normalize by library size were computed using the DESeq package59. 
Reads were further normalized by gene length.
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Affymetrix Human Gene Array 1.0 ST arrays from Gafni et al8 were processed with oligo 
package60 and normalized using Robust Multi-array Average61. Multiple probes mapping 
into the same gene were summarized into a single expression value by taking the max. 
Affymetrix PrimeView arrays from Theunissen et al10 were processed with Affy package62 
and normalized with RMA. Microarray differential expression analysis was performed using 
the limma package. RNA-seq and microarray data were combined as previously described9, 
expression levels were converted to log2 fold change relative to the mean of human embryo-
derived PSC samples within each study. One-to-one orthologous genes between mouse-
human were mapped as previously described9. PCA plot of all samples from all studies were 
generated using the princomp function from R stats package.
An alternative PCA analysis was performed where ComBat tool63 was applied to correct for 
batch effects and naïve samples were not normalized to primed samples. PCA was applied 
on batch effects-corrected, gene-wise mean-centered expression values.
Global metabolomic data analysis
Alll global metabolomic data was mean-centered within each sample prcomp function in R 
is used for Principle Component Analysis of metabolomics data. Differentially abundant 
metabolites were defined as metabolites with 2 fold change in abundance and Benjamini-
Hochberg adjusted false discovery rate <0.2.
For the lipidomics data, features missing in more than half of all samples (4 or more out of 
6) were removed from further analysis. Missing values were replaced with minimum 
detected values within each sample before mean-centering.
ChIP-seq data analysis
ChIP-seq data of H3K27me3 H3K4me3, H3K9me3 and H3K27ac modifications from Chan 
et al6, Gafni et al8, Theunissen et al10 and Bernstein et al64 was downloaded from Array 
Express, GEO, and ENCODE project website. Reads were aligned to hg19 using Bowtie 
version 1.0.0. allowing 1 mismatch (−N 1). ngsplot was used to generate plots of reads 
around 5 KB of transcription start sites of a priori defined developmental genes. Reads of 
replicate samples for the same cell type were merged for ngsplot. Reads with mapping 
quality above 20 were used by ngsplot. Differentially marked genomic regions were 
identified with diffReps version 1.55.465 and annotated to the closest genes. Genes 
associated with at least one significant genomic region (FDR less than 0.05 and fold change 
>1) were classified as differentially marked. When a gene is annotated with multiple 
significant genomic regions, the most significant one is assigned to that gene.
Lipid droplet visualization using Oil Red O and bodipy staining
Naïve and primed ESCs were fixed with 4% PFA at room temperature for 10min, washed 
twice with PBS and stained with Oil Red O dye (Sigma) for 10min at rt. Alternatively, lipid 
droplets were stained using BODIPY 493/503 (Molecular Probes) for 15min on a rocking 
platform at rt. Pictures were taken using a fluorescent microscope (Leica). Lipid droplet 
analysis at in vivo post-implantation stage has proven to be difficult.
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Protein extraction and Western blot analysis
Cellular extracts were prepared using a lysis buffer containing 20 mM Tris HCl (pH 7.5), 
150 mM NaCl, 15% glycerol, 1% Triton, 25mM β-glycerolphosphate, 50mM NaF, 10mM 
NaPyrophosphate, orthovanadate, PMSF (all chemicals are from Sigma-Aldrich, St. Louis, 
MO), Protease inhibitor cocktail (Roche) and 2% SDS. 25 U of Benzonase® Nuclease 
(EMD Chemicals, Gibbstown, NJ) and 20mM of DTT (Sigma) were added to the lysis 
buffer right before use. 15 µg of protein (determied by Bradford) was loaded, separated by 
4–20% SDS-PAGE, and transferred to polyvinylidene difluoride membranes, blocked with 
5% nonfat dry milk for 60 minutes at rt, and incubated overnight at 4°C with primary 
antibody. After incubation for one hour with horseradish peroxidase-conjugated secondary 
antibodies, they were visualized by enhanced chemiluminescence (Millipore Corp, Billerica, 
MA). Antibodies used in this study are: H3K27me3 (1/1000, Abcam, ab6002), H3K9me3 
(1/1000, Abcam, ab8898), H3K9/14Ac (1/1000, Cell Signaling, 9677s), EED (1/1000, gift 
from Dr. Bomsztyk66), HIF1α (1/2000, BD Biosciences, 610958), LDHA (1/1000, Cell 
Signaling, 3582), JARID2 (1/1000, Cell Signaling, 13594), pSTAT3 (1/1000, Abcam, 
Ab76315) and γ-tubulin (1/10000, Promega, G712A).
RNA extraction and qPCR analysis
RNA was extracted using trizol and analyzed by SYBRgreen qPCR with the 7300 real time 
PCR system (Applied Biosystems)67 and TaqMan qPCR (Applied Biosystems). Primers 
used are listed in Suppl.Table.2.
qPCR of miRNAs was conducted using TaqMan miRNA assays (Applied Biosystems). Raw 
Ct values for miRNAs were normalized to RNU66. Linear expression values for all qPCR 
experiments were calculated using the 2(−ΔCt) method. P-values were calculated using a 
student's t-test.
ChIP-seq experiment
Naïve hESCs Elf1 2iLIF grown on matrigel were treated with 100µM of STAT3 inhibitor 
(Selleckchem) for 6h or 24h and analyzed for methylation marks by Western blot and ChIP 
Seq. For ChIP-seq analysis, cells were crosslinked and chromatin processed as previously 
described67 with minor modifications. Briefly, cells were harvested with accutase and 
crosslinked in suspension with 1% formaldehyde solution for 10min at room temperature. 
Reaction was quenched with glycine and crosslinked cells were rinsed with ice-cold PBS. 
Nuclei were isolated and chromatin sonicated using a Covaris E210 to approximately 200–
500bp size range. ChIP-seq was conducted as previously described67 with minor 
modifications. Briefly, magnetic Dynabeads were incubated overnight rotating at 4C with 
antibody against H3K27me3 (Active Motif, cat # 39155). Sonicated chromatin from 
approximately 200 thousand cells was added to the bead-bound-antibodies and incubated at 
4C rotating overnight. Beads were washed and bound chromatin was eluted from beads and 
reverse crosslinked overnight. Purified DNA was prepared for next-generation sequencing 
via end repair, A-tailing, ligation of custom Y-adapters and PCR amplification to generate 
final DNA library following gel size selection.
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Generation of BAR-Elf reporter cell line
Elf1 cells grown in naïve media (2iL or 2iLIF) or primed media (AF) were infected with 
BAR reporter lentivirus33,68 and seeded onto matrigel-coated plates in MEF-CM with 10µM 
Y-27632, and 1µM Thiazovivin (ROCK inhibitors, Tocris). Transduced Elf cells were 
cultured for a week on matrigel, then passaged onto MEF plates for further selection and 
expansion. Single Elf1 naïve reporter cells were harvested via TrypLE Express and FACS 
sorted for the population with both Venus and DsRed positive signals. DsRed positive 
colonies of Elf1 primed reporter cells were transferred onto MEF plates, and the same 
positive selection was repeated 1–2 more rounds. Negative colonies were removed as a 
negative selection.
Manipulation of Wnt pathway
Wnt secretion and signaling were inhibited in naïve hESCs (Elf1, WIN1) by treatment with 
IWP2 (2µM, Torcis) or XAV939 (5µM, Sigma). Wnt pathway was activated in primed Elf1 
AF reporter cells using a GSK3 inhibitor, CHIR99021 (72h, 10µM, AxonMedChem). Both 
IWP2 and CHIR99021 were reconstituted in DMSO.
Production of Conditioned Medium (LCM and Wnt3A–CM )
L and L-Wnt3A cells (ATCC) were cultured in 15cm plate in 10% FBS/DMEM media until 
∼90% confluent. Medium was collected every 48hrs for three batches. Biological activity of 
secreted Wnt3A in the individual batches of the conditional medium was confirmed in 
293T–BAR reporter cells33, then batches were pooled and filtered. Primed (Elf1 AF) 
reporter cells were grown on matrigel with 50% LCM or 50% Wnt3A–CM for 3 days prior 
taking bright field and fluorescent pictures (Leica microscope).
RNA interference experiments
Naïve Elf1 2iLIF cells were transfected on matrigel in MEF-CM supplemented with ROCK 
inhibitors (Torcis) using Lipofectamine RNAiMAX (Life Technologies). siRNA targeting 
NNMT (Hs-NNMT-8) was purchased from Qiagen as Flexitube siRNA premix, and siRNA 
targeting luciferase was used as control. siRNAs against NNMT and luciferase were used at 
50nM final concentration. Protein and RNA were extracted 72h after transfection. siRNA 
targeting beta-catenin (Invitrogen, CTNNB1, Silencer Select ID s437) and Silencer Select 
Negative Control 1 (Invitrogen) were transfected in naïve Elf1 2iLIF cells at 10nM final 
concentration following a reverse transfection protocol. Bright field and fluorescence images 
were taken after 3 days. Efficacy was confirmed by qPCR analysis.
Overexpression of NNMT
Naïve hESCs were transfected with NNMT overexpression construct or inactive NNMT 
mutant overexpression construct (Y20A)28. Cells were plated the following day into 
matrigel coated Seahorse plates with primed hESC media (conditioned media + AF). 
Mitostress protocol in Seahorse flux analyzer was performed 2 days later. Alternatively, 
primed hESCs Elf1 AF were transfected with NNMT overexpression construct28 and 
proteins were extracted 3 days later for detection of H3K27me3 marks by Western blot 
analysis.
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Treatment of naïve hESCs with the metabolite SAM
WIN1 cells were seeded in Seahorse plates 2 days prior change of media with media without 
L-methionine (Sigma-Aldrich 0422 supplemented with 0.584 gm/L L-glutamine 
(Invitrogen)) and addition of SAM (500µM), 5hours later Seahorse mitostress protocol was 
performed.
HIF1α overexpression in naïve hESCs
Naïve hESCs (Elf1) were infected with a non-degradable form of HIF1α over-expressing 
construct (Addgene plasmid 19005, Yan et al.) or a pBABE empty vector construct in 
presence of 4 ng/ml Polybrene (Invitrogen). 24 days later RNA and proteins were harvested 
or media was changed into naïve hESC media with LIF but without GSK3 and MEK 
inhibitors (2i). Pictures were taken 3 days after infection and primed-like morphology of 
colonies quantified.
CRISPR-Cas9 based NNMT and HIF1 KO lines
Six gRNAs were designed for each of the genes NNMT and HIF1α using the GECKO 
library and Zhang website (mit.edu) and annealed and ligated into the LentiCRISPRv2 
(Addgene.com), which was previously digested with BsmB1 and dephosphorylated. The 
validated constructs were transfected using GeneJuice to naïve hESCs iCas9 Elf169 treated 
with doxycycline (2 µg/ml) for 1 or 2 days before and during transfection. On Day 3 the 
cells were trypsinized and replated on MEF-coated plates. On Day 6 single colonies were 
picked and amplified as described in Suppl.Fig8. Genomic DNA was harvested using 
DNAzol reagent (Invitrogen). NNMT KO 6-2–4 mutant was generated by transfecting in 
vitro transcribed gRNA to naïve hESC Elf1 iCas9 cells69. T7-gRNA in vitro transcription 
(IVT) template (120bp) was generated using T7 promoter-gRNA forward primer with a 
reverse primer against the scaffold. T7-gRNA PCR products were used as templates for IVT 
(MAXIscript T7 kit, Applied Biosystems). iCas9 Elf1 were treated with doxycycline 
(2µg/ml) for 1 or 2 days before and during transfection. For transfection, cells were 
dissociated with Trypsin, replated onto MEF-coated plates, and transfected in suspension 
with gRNAs using Lipofectamine RNAiMAX (Life Technologies). gRNA was added at a 10 
nM final concentration. A second transfection was performed after 24 hours. Two days after 
the last gRNA transfection, iCas9-Elf1 cells were dissociated into single cells and replated 
onto MEF coated plates. Single colonies were randomly selected and amplified. Genomic 
DNA was harvested using DNAzol. Genomic regions flanking the CRISPR target sites were 
PCR amplified, purified and send to Genewiz, Inc for sequencing. Alternatively, Samtools 
mpileup and BCF tools were used to identify variants based on aligned RNA-seq BAM files.
Teratoma formation
Naïve hESCs H1 4iLIF were cultured on Matrigel-coated plates. 2 × 106 cells were 
resuspended in Matrigel supplemented with a cocktail of prosurvival factors70 and injected 
into the femoral muscle of female 43–49 day-old SCID-Beige mice (Charles River, 
Wilmington, MA). Palpable tumor masses developed in approximately 5 weeks. The tumor 
bearing mice were sacrificed, tumor tissue was fixed in 10% formalin for 24h and stored in 
70% ethanol until paraffin imbedding. Five µm sections of the tumor were stained with 
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hematoxylin and eosin (Suppl.Fig.1D) Experiment was performed in compliance with 
ethical regulations, IACUC protocol # 4152-01.
Embryonic body (EB) formation
H1 4iLIF naïve-toggled cells were trypsinized and transferred into low attachment plates in 
differentiation medium (DMEM, high Glucose, 20% FBS, 0.1 mM NEAA, 2 mM L-
Glutamine, 1 mM Sodium Pyruvate, 1% Pen/Strep, 0.1 mM β-mercaptoethanol). The 
medium was changed every other day and whole genome RNA seq was performed after 2 
weeks (Suppl,Table1S).
Accession numbers
RNA-seq and ChIP-Seq data sets generated for this study are available from the NCBI GEO 
database under accession number GSE60955. Gene expression and ChIP-Seq data from 
Grow et al45 (GSE63570), Gafni et al8 (GSE52824), Chan et al6 (E-MTAB-2031 and E-
MTAB-2041), Theunissen et al10 (GSE59435), and Takashima et al9 (GSE60945) were also 
analyzed. mRNA-seq, microRNA-seq and ChIP-Seq of H1 and ChIP-Seq of H9 hESC cell 
lines from the ENCODE project were downloaded from the ENCODE project website 
hosted at UCSC genome brower (https://genome.ucsc.edu/ENCODE/). RNA-seq of multiple 
lineages derived from H1 hESC were downloaded from release 9 of the Roadmap 
Epigenome project (http://www.genboree.org/EdaccData/Current-Release/).
Reproducibility of experiments
Number of independent experiments for each figure panel is described in the corresponding 
figure legend and raw data is available in the “Statistics source data” supplemental table 4. 
For HIF1α, LDHA and JARID2 western blots in Elf1, Elf1 AF and H7, there were 3 
independent experiments (Fig.1J, 1M). For BODIPY 493/503 staining and Oil Red O of 
lipid droplets in primed and naïve human (Fig.3D, Suppl.Fig.3A–B) and mouse (Figure 3E) 
ESCs, there were 4 independent experiments. For western blots of histone marks and EED in 
Elf1, Elf1AF and H7 (Fig.5B) there were 3 to 8 independent experiments. For Western blots 
of histone marks in Elf1 and Elf1 treated with siRNA against NNMT or luciferase control 
(Fig.5D) and Elf1 treated with STAT3 inhibitor or DMSO control (Fig.5F) there were 3 
independent experiments. For Wnt sensor analysis in naïve and primed cells, there were 3 
independent experiments (Fig.6B–C, Suppl.Fig.6E–F) For western blot analysis of HIF1α 
expression in cells pushed toward the primed stage (Fig.7F), there were 3 independent 
experiments. For western blot of HIF1α expression and H3K27me3 marks in Elf1 CRISPR-
Cas9 KO mutants and control cells (Fig8E), there were 4 independent experiments. For 
teratoma generated from H1 4iLIF (Suppl.Fig.1D), there were 3 independent experiments. 
For western blot of H3K27me3 in Elf1 AF cells overexpressing NNMT (Suppl.Fig.4I), there 
were 3 independent experiments. For western blot of H3K27me3 mark in naïve WIN1 and 
WIN1 TeSR, there were 3 independent experiments (Suppl.Fig.5H). For western blot of 
HIF1α and H3K27me3 in WIN1 cells after transfection with siRNA against NNMT or 
luciferase (Suppl.Fig.5L) there were 3 independent experiments. For western blot of 
phosphorylated STAT3 in H1 and H1 2iF (Suppl.Fig.5M), there were 2 independent 
experiments. For morphology of Elf1 transfected with EV or HIF1α OE, there were 3 
independent experiments (Suppl.Fig.7B).
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There is no estimate of variation in each group of data and the variance is similar between 
the groups. No statistical method was used to predetermine sample size. The experiments 
were not randomized. The investigators were not blinded to allocation during experiments 
and outcome assessment. RNA samples with 260nm/280nm <1.80 were discarded.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Naïve and primed ESCs are metabolically different
A: PCA of RNA-seq data from this study (Elf1, H1 4i–LIF, Lis1, H1) and other 
studies6,9,45–46,. ComBat was applied on the combined RNA-seq dataset. B: Genes 
contributing to principal components separating primed vs. naïve hESC. Size of dots are 
proportional to the square of PC1 value. Top contributing genes are darker. C: Metabolic 
profile of naïve (Elf1, H1-4iLIF) and primed (H1) hESCs. A trace of OCR changes is shown 
under a MitoStress protocol (s.e.m, n=6 biological replicates). D: Primed hESCs (H7 and 
H1) have reduced OCR changes in response to FCCP compared to naïve hESCs (Elf1 and 
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H1-4iLIF), n=18 (H1, H1 4iLIF) or 24 (Elf1, H7) biological replicates; s.e.m.; p=0.122 for 
H14iLIFvs.Elf1, p=0.0001 for H1vs.Elf1, p=0.0014 for H7vs.Elf1; 2-tailed t-test. E-F: 
Transition of naïve hESCs Elf1 (E) and WIN1 (F) toward a more primed state by culture in 
ActivinA-FGF (AF) media reduced OCR changes in response to FCCP after 1 to 3 days 
(n=29 for Elf AF 1D, n=20 for Elf AF 2D, n=28 for Elf AF 3D, n=33 for Elf1, n=18 for 
WIN1 and WIN1 AF; s.e.m.; p=0.0013 for ElfAF1Dvs.Elf1, p<0.001 for ElfAF2Dvs.Elf1, 
ElfAF3Dvs. Elf1 and WIN1AFvs.WIN1; 2-tailed t-test). G: Heatmap log2 fold expression 
change of mitochondria complexes genes between primed and naïve stages10. H–I: Naïve 
hESCs (Elf1) and primed hESCs (Elf1 AF) have similar mitochondrial DNA copy number 
(H,n=3) and mitochondrial mutation frequencies (I,n=3). S.e.m.; p=0.7802 (H), p=0.37 and 
0.6 (I); 2-tailed t-test. J: HIF1α protein is stabilized in primed hESCs (H7 and Elf1 AF). K: 
Proteomic workflow used to identify differentially regulated protein expression in primed vs. 
naive hESCs. L: Volcano plot of differentially expressed proteins in primed hESCs (right, 
green; Elf1 AF) vs naïve cells (left, blue, Elf1). Significant hits are shown (FDR<0.05). 
Proteins were quantified by nano-LC-MS/MS on a Fusion Orbitrap. M: JARID2 and LDHA 
proteins are upregulated in primed hESCs (Elf1 AF and H7) compared to naïve hESCs 
(Elf1), as revealed by Western blot analysis. Unprocessed original scans of blots are shown 
in Supplementary Suppl.Fig.9. For raw data, see Supplementary Table 4. n=number of 
biological replicates.
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Figure 2. Metabolomic analysis of naïve and primed ESCs
A: Scheme of mass spectrometry experiments performed for metabolites on mouse and 
human naïve (pre-implantation) and primed (post-implantation) ESCs. B-C: naïve and 
primed stem cells can be clearly separated based on their metabolic profiles. (B) PCA plot of 
water-soluble untargeted GC-MS metabolomics data. The first principal component (PC), 
which separates the primed cell types (left) from the naïve cell types (right) explained 50.5% 
of total variance. (C) PCA plot of untargeted LC metabolomics data. 3 clusters are along the 
first PC: primed cells (left), primed cells toggled back to naïve cells (middle) and naïve cells 
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(right). The first PC explained 68.2% of total variance. D–G: volcano plots of differentially 
abundant metabolites between primed and naïve cells in mESCs (D, E) detected by GC-
TOF, and hESCs (F: GC-TOF, G: LC-QQQ-MS). x-axis is log2 fold change of abundance, 
y-axis is negative log10 of p-value. Metabolites of biological interest for further analysis are 
labeled. H: Visualization of the glycolysis pathway and connections to lipid and amino acid 
synthesis. I: Fold change of glycolysis metabolites (n=3, s.e.m.; Glucose (p=0.6630), G1P-
G6P-F6P-F1P (p=0.3713), F16BP-F26BP (p=0.0070), D-GA3P-DHAP (p=0.0058), PEP 
(p=0.1925), Pyruvate (p=0.1416); 2-tailed t-test) after log2 transformation and mean 
centering in H1 vs. Elf1 detected by targeted LC-QQQ-MS. For raw data, see 
Supplementary Tables 1 and 4. n=number of biological replicates.
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Figure 3. Primed ESCs accumulate lipids while naïve ESCs use fatty acids as a source of energy
A–B: More abundant lipids in primed hESCs (H1) have more carbon atoms (A) and larger 
mass (B) than more abundant lipids in naïve hESCs (Elf1). C: More abundant lipids in 
primed mESCs (R1AF) are more unsaturated than more abundant lipids in naïve mESCs 
(R1). n=6, p-values Wilcoxon ranksum test. Boxes represent median, 25th and 75th quantiles. 
Whiskers extend 1.5 IQR above 75th quantile and below 25th quantile. Dots represent values 
beyond whiskers. D-E: BODIPY 493/503staining shows an increase of lipid droplet 
accumulation in primed human (Elf1, D) and mouse (EpiSCs, E) ESCs compared to naïve 
human (Elf1 AF, D) and mouse (R1, E) ESCs. Scale bar, 50µm. F: CPT1A is downregulated 
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in human and mouse primed ESCs compared to naïve ESCs in our study and others. n= from 
left to right (primed, naïve): 2,1; 3,3; 2,5; 3,3; 3,3; 3,9; 3,2. Negative binomial test p-values 
are shown. G: ChIP-seq analysis of CPT1A gene shows more repressive H3K27me3 marks 
and less active H3K4me3 and H3K27ac marks in primed hESCs (C1, WIBR38, H1, H945) 
than naïve hESCs (Elf112; naïve C1, naïve BGO1, naïve WIBR38). H: volcano plot, 
microRNA expression in naïve hESCs (Elf1) and primed hESCs (H1, ENCODE, suppl. table 
1M). I: qPCR expression of hsa-miR-9 and hsa-miR-10a (predicted to target CPT1A and 
FASN respectively). hsa-miR-10a is 34-fold higher, and hsa-miR-9 is 4-fold lower in Elf1 
vs.H1 (n=3, s.e.m; miR-10a: p=0.004, miR-9: p=0.022; 2-tailed t-test). J-L: Seahorse 
palmitate assay shows that naïve human and mouse ESCs use fatty acids as a source of 
energy. A trace of OCR changes after palmitate or BSA vehicle addition, followed by ETO 
in human ESCs (naïve Elf1 and primed H7, J) and mouse ESCs (naïve R1 and primed 
EpiSCs, K). n=4 for Elf1BSA, R1BSA, EpiBSA, n=5 for Elf1PALM, R1PALM, EpiPALM, 
n=6 for H7BSA, H7PALM; s.e.m. Changes after ETO injections were quantified in L 
(Elf1BSA (n=12), R1BSA (n=12), EpiBSA (n=12), Elf1PALM (n=15), R1PALM (n=15), 
EpiPALM (n=15), H7BSA (n=18), H7PALM (n=18), s.e.m.; naïve hESCs: p=0,0096, 
primed hESCS: p=0.354, naïve mESCs: p=0.03, primed mESCs: p=0.88, 2-tailed t-test). For 
raw data, see Supplementary Table 4. n=number of biological replicates.
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Figure 4. Amino acids methionine and tryptophan are differentially regulated in naïve and 
primed hESCs
A: Model of Tryptophan-Kynurenine pathway. B: IDO1 is highly expressed in primed 
hESCs as compared to naïve hESCs (qPCR, n=3 for H14iLIF, ElfAF, n=4 for H12iF, H1, 
H7, n=5 for Elf 2iLIF; s.e.m.; ***p<0.001; 2-tailed t-test). C: The kynurenine vs. tryptophan 
ratio is higher in primed than naïve hESCs, as detected by targeted (n=6) and non-targeted 
(HILIC: n=4, QQQ n=3) mass spectrometry. s.e.m.; *p<0.05, **p<0.01, ***p<0.001; 1-
tailed t-test,). D: Model of SAM pathway and NNMT. Metabolites in red are up-regulated in 
primed hESCs. Metabolites and enzymes in blue are up-regulated in naïve hESCs. E: 
Volcano plot of RNA-seq data from naïve hESCs (Elf1) and primed hESCs (H1). Genes with 
greater than 2-fold change and FDR<0.05 are colored. NNMT and IDO1 are among the 
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most differentially expressed genes. F: NNMT is highly up-regulated in naïve hESCs 
compared to primed hESCs (qPCR). Numbers indicate fold changes of naïve hESCs 
compared to H1 and H7 primed hESCs. (n=3 for WIN1, H75iLAF, Elf1, H14iLIF, H14iLTF, 
LIS1, WIN1F, Elf1AF, n=4 for WIN15iLA, H12iF, H1, H7, n=5 for H75iLIF; s.e.m.; 
***p<0.001; 2-tailed t-test) G: Naïve hESCs (n=4 each) have higher amounts of the 1-MNA, 
than primed hESCs (n=4 for H1, n=6 for WIN1TeSR, ElfAF) (s.e.m. ***p<0.001, 2-tailed t-
test). 1-MNA was not detected in Elf1 CRISPR-Cas9 KO mutant of NNMT (gNNMT 7.2.1, 
n=6; gNNMT 6.2.4, n=6). H: SAM levels are higher in primed hESCs (H1 n=4, Elf AF n=6) 
than in naïve hESCs (Elf1 n=4) (s.e.m.; p=0.0089 for ElfAF vs. Elf1, p=0.0376 for H1 vs. 
Elf1; 2-tailed t-test). I-J: SAM induces a “primed-like” metabolic profile in naïve hESCs. 
Addition of SAM (500µM) for 5h in media without methionine reduces OCR changes in 
response to FCCP in naïve hESCs (WIN1). A Seahorse trace is shown in I (n=6; s.e.m). 
OCR changes after FCCP are quantified in J (n=23; s.e.m.; p=0.017). K: Overexpression of 
NNMT delays the metabolic transition from naïve to primed (n=4; s.e.m.; p=0.028, 2-tailed 
t-test). For raw data and exact p values, see Supplementary Table 4. n=number of biological 
replicates.
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Figure 5. High NNMT expression in naïve hESCs regulates histone methylation status
A: H3K27me3 reads mapped 5kb around transcription start sites (TSS) of 648 
developmental genes were plotted for Ware et al., Gafni et al., Theunissen et al., Bernstein et 
al. (left panel) and Chan et al (right panel) ChIP-seq data sets. B: Western blot analyses 
show higher H3K27me3 and H3K9me3 in primed hESCs (H7, Elf1 AF) than naïve hESCs 
(Elf1). C: qPCR analysis shows a knock-down regulation of NNMT using siRNA (50 nM, 
72h) in naïve hESCs (Elf1), inducing a decrease of 1-MNA levels (qPCR n=3; s.e.m., 
p=0.001, 2-tailed t-test; HILIC n=4, s.e.m., p=0.039 1-tailed t-test) D: Western blot analysis 
Sperber et al. Page 31
Nat Cell Biol. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of histone marks in Elf1 cells treated with siRNA against NNMT or siRNA against 
luciferase as a control. E: Hypergeometric test p-values for the overlap between genes 
expressed higher (lower) in siNNMT compared to siLUC and genes expressed higher 
(lower) in primed lines compared to naïve lines from multiple studies. Color shade is 
proportional to negative log10 of p-values. siLUC transcriptomic signature has significant 
overlap with the ELFAF vs. Elf1 data set. F: Western blot analysis of histone modifications 
after treatment of Elf1 cells with 100 µM of STAT3 inhibitor. G: 6h treatment with STAT3 
inhibitor (100 µM) in Elf1 cells increases H3K27me3 marks, as shown by ChipSeq analysis 
on all genes. H: WNT ligands and EGLN1 are among the 313 overlapping genes with 
increased H3K27me3 mark in primed vs. naïve hESCs (8,10,64), and Elf1 cells treated for 6h 
with 100uM STAT3 inhibitor vs. Elf1 cells. I: Windowed chromatin heatmaps of H3K27me3 
profile +/− 5kb of promoters of the 313 overlapping genes with increased H3K27me3. J: 
H3K27me3 reads from ChIP-seq data mapped 5kb around TSS were plotted for naïve 
hESCs (C1, WIBR3, BGO18, and Elf112.), primed hESCs (C1, WIBR38, H112) and naïve 
hESCs Elf1 treated for 6h with 100µM of STAT3 inhibitor. Unprocessed original scans of 
blots are shown in Supplementary Fig.9. For raw data, see Supplementary Table 4. n= 
number of biological replicates.
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Figure 6. WNT pathway is active in naïve hESCs
A: Heatmap of gene expression of WNT ligands and WNT targets in primed hESCs (H1, 
Elf1 AF) and naïve hESCs (Elf1). B: Wnt is activated in naïve hESCs. Endogenous Wnt 
signaling in naïve (Elf1) and primed (Elf1 AF) BAR-reporter cells. Scale bars represent 
200µm. C: Wnt inhibitor IWP2 (2µM) and Wnt antagonist XAV939 (5µM) inhibit the 
reporter activity in naïve Elf1 cells after 72h. Scale bars represent 200µm. D: Wnt inhibition 
by IWP2 (2µM, 48h) decreases OCR changes after FCCP in naïve hESCs (Elf1, WIN1) and 
in naïve hESCs transitioning to primed (WIN1 AF). A trace of OCR changes is presented in 
Elf1 (n=8 for Elf1, n=6 for Elf1+IWP2; s.e.m.). OCR changes after FCCP were quantified 
(n=8 for Elf1, n=6 for Elf1+IWP2, WIN1, WIN1+IWP2, WIN1AF, n=7 for WIN1AF
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+IWP2; s.e.m.; p=0.0009 for Elf1+IWP2 vs. Elf1, p=0.0084 for WIN1+IWP2 vs. WIN1, 
p=0.0006 for WIN1AF+IWP2 vs. WIN1AF; 2-tailed t-test). E: Wnt inhibition by IWP2 
(2µM, 72h) downregulates NNMT and miR-372 expression in naïve hESCs (Elf1) as shown 
by qPCR analysis. (n=3; s.e.m.; p=0.04 for miR-372, p=6.44E-06 for NNMT; 1-tailed t-test). 
F: Model of self-reinforcing loop between WNT and NNMT in primed hESCs. For raw data, 
see Supplementary Table 4. n= number of biological replicates.
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Figure 7. HIF1α is required for naïve to primed hESC transition
A: screen shot of RNA expression and H3K27me3 marks of EGLN1 (PHD2) in naïve 
hESCs [Elf112, WIRB3 naïve and BGO1 naïve8)], primed hESCs [WIRB3 primed8, H1 and 
H964 and Elf1 treated with STAT3 inhbitor (100 µM) for 6h. B: HIFα is hydroxylated on 
prolyl residues by EGLN1 (PHD2), leading to VHL-mediated proteolysis. C-D: Sequencing 
trace files, DNA sequences and protein sequences of HIF1α CRISPR-Cas9 knock-out (KO) 
mutant clones (gHIF1 6.2.1, C; gHIF1 6.3.1, D). E: schematic representation of wild type 
HIF1α protein and proteins resulting from CRISPR-Cas9 knock-out (KO) mutants gHIF1 
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6.2.1 and gHIF1 6.3.1. bHLH= basic helix-loop-helix domain, PAS= Per-Arnt-Sim domain, 
NTAD= N-terminus transcriptional activation domain, CTAD= C-terminus transcriptional 
activation domain. F: HIF1α is not expressed in CRISPR-Cas9 KO mutants. Western blot 
analysis of HIF1α expression in cells pushed toward the primed stage by culture in TeSR1 
for 5 days in wild type Elf1 cells (iCas9 Elf1), and two CRISPR-Cas9 KO mutants of HIF1α 
(gHIF1 6.2.1 and gHIF1 6.3.1). G: qPCR analysis of hESCs transitioning to primed reveals 
that naïve markers (DNMT3L and NNMT) are still expressed higher in Elf1 HIF1α 
CRISPR-Cas9 KO cells compared to wild type Elf1, while primed marker IDO1 and HIF 
target genes (PDK1 and VEGFA) are downregulated (n=3; s.e.m.; p=0.024 for DNMT3L, 
p=0.0005 for NNMT, p=0.001 for IDO1, p=0.12 for PDK1, p=0.004 for VEGFA; 2-tailed t-
test). H: KO of HIF1α prevents the metabolic switch occurring during the transition of 
hESCs from naïve to primed state as shown by measuring OCR after FCCP addition using 
SeaHorse. n=3 for gHIF1 6.3.1 2iLIF and AF and n=4 for Elf iCas9 and gHIF1 6.2.1 2iLIF 
and AF; s.e.m.; p=0.0117 for gHIF1 6.2.1 vs. Elf iCas9, p=0.0032 for gHIF1 6.3.1 vs. Elf 
iCas9; 2-tailed t-test. Unprocessed original scans of blots are shown in Supplementary Fig.9. 
For raw data, see Supplementary Table 4. n= number of biological replicates.
Sperber et al. Page 36
Nat Cell Biol. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 8. NNMT affects naïve to primed hESC transition by repressing Wnt pathway and 
activating HIF pathway
A–B: Sequencing trace files, DNA sequences, protein sequences and 3D protein structures 
predicted from sequence (Pymol) of various NNMT CRISPR-Cas9 KO mutant clones 
(gNNMT 7.2.1, A; gNNMT 6.2.4, B). Green color represents the truncated NNMT protein 
in the CRISPR-Cas9 mutant. C: Schematic representation of wild type NNMT protein and 
proteins resulting from the CRISPR-Cas9 KO mutants gNNMT 7.2.1 and gNNMT 6.2.4. D: 
Elf1 NNMT CRISPR-Cas9 KO cells have higher amounts of SAM than wild type Elf1 cells 
(n=6; s.e.m.; p=1.23E-05 for gNNMT7.2.1, p=5.47E-06 for gNNMT6.2.4; 2-tailed t-test). E: 
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Western blot analysis reveals higher HIF1α expression and H3K27me3 marks in Elf1 
CRISPR-Cas9 KO mutants gNNMT 7.2.1 and gNNMT 6.2.4 compared to control Elf1 
(iCas9) cells. F: qPCR analysis of the naïve marker DNMT3L in wild type Elf1 cells (n=6) 
and Elf1 CRISPR-Cas9 KO mutants gNNMT 7.2.1 (n=5) and gNNMT 6.2.4 (n=3). s.e.m.; 
p=0.0009 for gNNMT 6.2.4 vs. Elf1, p=0.027 for gNNMT 7.2.1 vs. Elf1; 2-tailed t-test. G: 
log2 fold expression change of NNMT, WNT ligands and HIF target genes in Elf1 CRISPR-
Cas9 KO gNNMT 7.2.1 compared to wild type Elf1 cells (RNAseq). H: PCA plot of 
CRISPR NNMT knockout line and different naïve and primed lines sequenced in this study. 
gNNMT 6.2.2 and gNNM 7.3.5 are heterozogous controls. PC1 (x-axis) explains majority of 
the variation in the data (61%), and the gNNMT 7.2.1 knockdown line moved along x-axis 
substiantially away from other naïve lines and toward the primed state. I: Hypergeometric 
test p-values for the overlap between genes expressed higher (lower) in gNNMT 7.2.1 
compared to Elf1 and genes expressed higher (lower) in primed lines compared to naïve 
lines from multiple studies. Color shade is proportional to negative log10 of p-values. 
gNNMT 7.2.1 transcriptomic signature has significant overlap with all published primed 
transcriptomic datasets, supporting its transition toward a primed stage. J: Model of the 
intricate relationship between metabolism and epigenetic in hESCs. Unprocessed original 
scans of blots are shown in Supplementary Fig.9. For raw data, see Supplementary Table 4. 
n= number of biological replicates.
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